A. D. DAVID MACKAY - 29 Dec 2023 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
29 Dec 2023
Net transactions value
$0
Form type
4
Filing time
03 Jan 2024, 16:46:02 UTC
Previous filing
18 May 2023
Next filing
08 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +51 +0.78% $0.000000 6,568 10 Feb 2023 Common Stock 51 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +46 +0.7% $0.000000 6,613 12 May 2023 Common Stock 46 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +51 +0.78% $0.000000 6,665 25 Aug 2023 Common Stock 51 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +60 +0.91% $0.000000 6,725 09 Nov 2023 Common Stock 60 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1,117 +17% $0.000000 7,842 29 Dec 2023 Common Stock 1,117 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.